Recombinant erythropoietin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Recombinant erythropoietin, covering 2009-05-29 to 2019-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBI [Phase 2]